04 Apr, EOD - Indian

SENSEX 75364.69 (-1.22)

Nifty 50 22904.45 (-1.49)

Nifty Bank 51502.7 (-0.18)

Nifty IT 33511.4 (-3.58)

Nifty Midcap 100 50645.95 (-2.91)

Nifty Next 50 61468.7 (-2.59)

Nifty Pharma 20560 (-4.03)

Nifty Smallcap 100 15675.95 (-3.56)

04 Apr, EOD - Global

NIKKEI 225 33780.58 (-2.75)

HANG SENG 22849.81 (-1.52)

S&P 5103.84 (-5.79)

Login/Signup
Careers
LOGIN HERE
Cancel

companylogoVaishali Pharma Ltd

You are Here : Home > Markets > CompanyInformation > Board Meeting
BSE Code : 535000 | NSE Symbol : VAISHALI | ISIN : INE972X01022 | Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln |


Board Meeting
Announcement Date Date Of Meeting Purpose Detail
19-Feb-2025 19-Feb-2025 Acquisitions Vaishali Pharma Limited has informed the Exchange regarding Board meeting held on February 19, 2025.
31-Jan-2025 06-Feb-2025 Quarterly Results To consider and approve the financial results for the period ended December 31, 2024 and other business matters Vaishali Pharma Limited has informed the Exchange regarding Board meeting held on February 06, 2025. (As Per NSE Announcement Dated on: 06.02.2025)
24-Jan-2025 28-Jan-2025 Change in Directors To consider other business matters Vaishali Pharma Limited has informed the Exchange regarding Board meeting held on January 28, 2025. (As Per NSE Announcement Dated on: 29/01/2025)
07-Nov-2024 14-Nov-2024 Quarterly Results To consider and approve the financial results for the period ended September 30, 2024 Vaishali Pharma Limited has informed the Exchange regarding Board meeting held on November 14, 2024. (As Per NSE Announcement Dated on: 14/11/2024)
17-Oct-2024 17-Oct-2024 Bonus Issue Vaishali Pharma Limited has informed the Exchange that the Board of Directors at its meeting held on October 17, 2024, have considered and approved bonus at the ratio of 1 : 1, i.e 1 Equity Shares for every 1 Equity Shares held.
08-Oct-2024 10-Oct-2024 Expansion To consider other business matters Vaishali Pharma Limited has informed the Exchange regarding Board meeting held on October 10, 2024. (As Per NSE Announcement Dated on: 10/10/2024)
24-Sep-2024 03-Oct-2024 Change in Directors To consider other business matters. Vaishali Pharma Limited has informed the Exchange regarding Board meeting held on October 03, 2024. (As Per NSE Announcement Dated on: 03/10/2024)
22-Aug-2024 28-Aug-2024 Bonus Issue To consider bonus and other business matters Vaishali Pharma Limited has informed the Exchange regarding Board meeting held on August 28, 2024. (As Per NSE Announcement Dated on: 28/08/2024)
06-Aug-2024 14-Aug-2024 Quarterly Results To consider and approve the financial results for the period ended Jun 30, 2024 Vaishali Pharma Limited has submitted to the Exchange, the financial results for the period ended June 30, 2024. Vaishali Pharma Limited has informed the Exchange regarding Outcome of Board Meeting held on August 14, 2024. (As Per NSE Announcement Dated on: 14/08/2024)
16-Jul-2024 16-Jul-2024 Conversion Vaishali Pharma Limited has informed the Exchange regarding Outcome of Board Meeting held on July 16, 2024.
11-Jul-2024 11-Jul-2024 Conversion Vaishali Pharma Limited has informed the Exchange regarding Outcome of Board Meeting held on July 11, 2024.
28-Jun-2024 28-Jun-2024 Conversion Vaishali Pharma Limited has informed the Exchange regarding Board meeting held on Jun 28, 2024.
07-Jun-2024 07-Jun-2024 Conversion Vaishali Pharma Limited has informed the Exchange regarding Board meeting held on Jun 07, 2024.
23-May-2024 30-May-2024 Quarterly Results To consider and approve the financial results for the period ended March 31, 2024 Vaishali Pharma Limited has submitted to the Exchange, the financial results for the period ended March 31, 2024. (As Per NSE Announcement Dated on: 30/05/2024)
17-May-2024 17-May-2024 Conversion Vaishali Pharma Limited has informed the Exchange regarding Board meeting held on May 17, 2024.
1 2 3 

Capital Market Publishers India Pvt. Ltd

401, Swastik Chambers, Sion Trombay Road, Chembur, Mumbai - 400 071, India.
+91-22-25229720
+91-9769005430
>info@capitalmarket.com

For any Capital Market Website related queries mail to :
webdesk@capitalmarket.com

For Capital Market Magazine subscription queries :
+91-8657545825  

subscription@capitalmarket.com

For Capital Market Online Product related queries :
+91-8657545825  

financeshop@capitalmarket.com

To advertise on Capital Market Websites mail to :
advt@capitalmarket.com

To email Press Releases :
pressrelease@capitalmarket.com

Kindly note www.capitalmarket.com does not send any mobile SMS, whatsapp or twitter messages giving any kind of stock recommendations.

Formed in 1986, Capital Market Publishers India Pvt Ltd pioneered corporate databases and stock market magazine in India. Today Capitaline corporate database cover more than 35,000 listed and unlisted Indian companies. Latest technologies and standards are constantly being adopted to keep the database user-friendly, comprehensive and up-to-date.

Over the years the scope of the databases has enlarged to cover economy, sectors, mutual funds, commodities and news. Many innovative online and offline applications of these databases have been developed to meet various common as well as customized requirements.

While all the leading institutional investors use Capitaline databases, Capital Market magazine gives access to the databases to individual investors through Corporate Scoreboard. Besides stock market and company-related articles, the magazine’s independent and insightful coverage includes mutual funds, taxation, commodities and personal finance.

The power of the database is harnessed by our fired-up reporters to generate interesting ideas. The reader-friendly presentation of the idea, supplemented by relevant data and information, can be accessed online through Capita Telefolio and Telefolio Gold. These ideas are used by individual investors as well as institutional investors to do further research and stay ahead.

Copyright @ Capital Market Publishers India Pvt.Ltd

Designed, Developed and maintained by CMOTS Infotech (ISO 9001:2015 Certified)

Site best viewed in Internet Explorer Edge ,   Google Chrome 115.0.5790.111 + ,   Mozilla Firefox 115.0.3 + ,   Opera 30.0+, Safari 16.4.1 +